Long ‐term survival of patients with mismatch repair protein‐deficient, high‐stage ovarian clear cell carcinoma

ConclusionsLarger studies are required but high‐stage, MMR protein‐deficient CCCs may have a relatively favourable prognosis.

Source: Histopathology - September 20, 2016 Category: Pathology Authors: Colin J R Stewart, David D L Bowtell, Dorota A Doherty, Yee C Leung Tags: Short Report Source Type: research